On January 16, 2026, the U.S. Supreme Court announced its intent to hear the case of Hikma v. Amarin. This case follows the landmark GSK v. Teva ...

Health care workers are changing how they counsel patients. Experts are using our database to support their research. And ...

Parents of autistic children are clamoring for a prescription vitamin promoted by federal health officials. But there's ...

The dataset powers our Rx Inspector tool, which lets you find the factories that made your generic drugs and their FDA ...

The Mecosta County Board of Commissioners approved a request for proposals for funding from the opioid settlement during its ...

Detailed price information for Teva Pharmaceutical Industries ADR (TEVA-N) from The Globe and Mail including charting and ...

Both ANI Pharmaceuticals ANIP and Teva Pharmaceuticals TEVA operate in the pharmaceutical sector, focusing on generic and ...

In 2023, Teva made a pledge to bolster its innovative medicines portfolio without leaving behind its century-long legacy as a ...

Health Canada approved last month two  brand names for generic semaglutide products, Plosbrio  and  Poviztra, which contain ...

The green shoots suggesting a comeback was in sight for biotech stocks last year have mostly grown into proverbial flowering plants—but one company’s precipitous year-over-year decline in market ...

The U.S. FDA has approved Zycubo (copper histidinate, CUTX-101) as the first treatment for Menkes disease, a rare, genetic disease affecting children who cannot absorb copper through their intestines, ...

Teva Pharmaceuticals TEVA announced a funding agreement with Royalty Pharma plc RPRX, under which the latter will provide up to $500 million to accelerate the development of Teva’s anti-IL-15 antibody ...